Rank: 46 (Previous rank: 47)
Compare tool: Pfizer vs. Top 10
CEO: Jeffrey B. Kindler
Address: 235 E. 42nd St.
New York, NY 10017
It's already the world's largest drug maker, but Pfizer's $68 billion acquisition of Wyeth makes it a true giant, with annual revenues that are expected to be 55% higher than No. 2 GlaxoSmithKline. Pfizer's bane continues to be impending patent expirations for blockbuster drugs - especially Lipitor in 2011 - without anything to fill the gaps.
Last summer Pfizer stopped its practice of funding medical-education courses taught by third parties, as a response to critics who say drugmakers exert unethical influence on physicians. - J.Y.
What Readers Say
They speak out on Exxon Mobil and other 500 companies...